awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q50149863-4ECAFCA9-BEC9-4693-8B02-49D898D52EB1
Q50149863-4ECAFCA9-BEC9-4693-8B02-49D898D52EB1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50149863-4ECAFCA9-BEC9-4693-8B02-49D898D52EB1
Radioimmunotherapy for delivery of cytotoxic radioisotopes: current status and challenges.
P2860
Q50149863-4ECAFCA9-BEC9-4693-8B02-49D898D52EB1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50149863-4ECAFCA9-BEC9-4693-8B02-49D898D52EB1
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0b1a762cdc554d6eb76748696449b24acd755ce7
P2860
(90)Y-labelled anti-CD22 epratuzumab tetraxetan in adults with refractory or relapsed CD22-positive B-cell acute lymphoblastic leukaemia: a phase 1 dose-escalation study.